Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 17.10% and Operating profit at 20.91% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 9.56% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 17.10% and Operating profit at 20.91% over the last 5 years
3
Flat results in Mar 25
4
With ROE of 12.77%, it has a expensive valuation with a 1.22 Price to Book Value
Stock DNA
Chemicals & Petrochemicals
CNY 3,164 Million (Small Cap)
10.00
NA
1.02%
0.68
12.77%
1.22
Revenue and Profits:
Net Sales:
965 Million
(Quarterly Results - Jun 2025)
Net Profit:
107 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.12%
0%
-7.12%
6 Months
7.79%
0%
7.79%
1 Year
5.55%
0%
5.55%
2 Years
-2.35%
0%
-2.35%
3 Years
2.35%
0%
2.35%
4 Years
-28.39%
0%
-28.39%
5 Years
-18.26%
0%
-18.26%
Hubei Kailong Chemical Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.10%
EBIT Growth (5y)
20.91%
EBIT to Interest (avg)
2.50
Debt to EBITDA (avg)
3.75
Net Debt to Equity (avg)
0.62
Sales to Capital Employed (avg)
0.74
Tax Ratio
14.02%
Dividend Payout Ratio
31.29%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.44%
ROE (avg)
9.56%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.22
EV to EBIT
10.84
EV to EBITDA
6.06
EV to Capital Employed
1.13
EV to Sales
1.31
PEG Ratio
0.15
Dividend Yield
1.02%
ROCE (Latest)
10.44%
ROE (Latest)
12.77%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
964.60
952.20
1.30%
Operating Profit (PBDIT) excl Other Income
235.00
191.50
22.72%
Interest
19.60
28.20
-30.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
106.90
58.20
83.68%
Operating Profit Margin (Excl OI)
153.30%
110.70%
4.26%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 1.30% vs 3.69% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 83.68% vs -44.73% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
3,644.90
3,742.80
-2.62%
Operating Profit (PBDIT) excl Other Income
785.10
785.30
-0.03%
Interest
119.50
149.90
-20.28%
Exceptional Items
-35.50
-14.60
-143.15%
Consolidate Net Profit
256.50
246.90
3.89%
Operating Profit Margin (Excl OI)
117.70%
118.30%
-0.06%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -2.62% vs 10.90% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 3.89% vs 58.57% in Dec 2023
About Hubei Kailong Chemical Group Co., Ltd. 
Hubei Kailong Chemical Group Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






